<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727475/" ref="ordinalpos=3365&amp;ncbi_uid=1947267&amp;link_uid=PMC2727475" image-link="/pmc/articles/PMC2727475/figure/F1/" class="imagepopup">Figure 1. The Wnt/β-Catenin <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>.  From: Wnt/?-Catenin <span class="highlight" style="background-color:">Signaling</span> Acts at Multiple Developmental Stages to Promote Mammalian Cardiogenesis. </a></div><br /><div class="p4l_captionBody">Canonical Wnt signaling is initiated when Wnts bind to their cognate receptor complex of the transmembrane proteins Frizzled and Lrp. This interaction activates the cytoplasmic protein Dishevelled, which stabilizes β-catenin by inhibiting the kinase activity of the destruction complex of adenomatous polyposis coli (APC), Axin, and glycogen synthase kinase-3β (GSK3β). Unphosphorylated β-catenin on its N-terminus translocates into the nucleus, where it interacts with the TCF/lymphoid enhancer factor (LEF) transcription factors to activate Wnt target genes. In the absence of Wnt, the destruction complex phosphorylates β-catenin, targeting it for degradation.</div></div>